Related Experiment Video
Updated: Mar 24, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Survival in Patients with Degenerative Mitral Stenosis: Results from a Large Retrospective Cohort Study
Ioana Pasca1, Patricia Dang2, Gaurav Tyagi2
1Division of Anesthesiology, Loma Linda University Medical Center, Loma Linda, California.
Insights
Survival for patients with severe mitral annular calcification causing degenerative mitral stenosis (DMS) is poor. Age, renal insufficiency, atrial fibrillation, and other valve issues worsen prognosis, while certain medications may improve survival.
Area of Science:
- Cardiology
- Valvular Heart Disease
- Echocardiography
Background:
- Severe mitral annular calcification (MAC) causing degenerative mitral stenosis (DMS) is a growing concern in valve intervention patients.
- The clinical profile, natural history, and survival factors in DMS patients are not well-understood.
Purpose of the Study:
- To characterize factors influencing survival in patients diagnosed with degenerative mitral stenosis (DMS).
Main Methods:
- A cohort of 1,004 patients with DMS was identified from an institutional echocardiographic database.
- Survival analysis was performed using clinical, pharmacologic, and echocardiographic variables.
Main Results:
- 1- and 5-year survival rates were 78% and 47%, respectively, with worse outcomes in higher DMS grades.
- Risk factors for mortality included older age, atrial fibrillation, renal insufficiency, mitral/tricuspid regurgitation, elevated right atrial pressure, aortic stenosis, and low albumin.
- Renin-angiotensin system blockers and statins were associated with better survival; digoxin use correlated with higher mortality.
Conclusions:
- Prognosis for DMS patients is poor, particularly in the elderly and those with comorbidities like renal insufficiency and atrial fibrillation.
- Concomitant valvular lesions also negatively impact survival.
- Renin-angiotensin system blockers and statins may offer survival benefits, while digoxin use warrants caution.
Background:
Severe mitral annular calcification causing degenerative mitral stenosis (DMS) is increasingly encountered in patients undergoing mitral and aortic valve interventions. However, its clinical profile and natural history and the factors affecting survival remain poorly characterized. The goal of this study was to characterize the factors affecting survival in patients with DMS.
Methods:
An institutional echocardiographic database was searched for patients with DMS, defined as severe mitral annular calcification without commissural fusion and a mean transmitral diastolic gradient of ≥2 mm Hg. This resulted in a cohort of 1,004 patients. Survival was analyzed as a function of clinical, pharmacologic, and echocardiographic variables.
Results:
The patient characteristics were as follows: mean age, 73 ± 14 years; 73% women; coronary artery disease in 49%; and diabetes mellitus in 50%. The 1- and 5-year survival rates were 78% and 47%, respectively, and were slightly worse with higher DMS grades (P = .02). Risk factors for higher mortality included greater age (P < .0001), atrial fibrillation (P = .0009), renal insufficiency (P = .004), mitral regurgitation (P < .0001), tricuspid regurgitation (P < .0001), elevated right atrial pressure (P < .0001), concomitant aortic stenosis (P = .02), and low serum albumin level (P < .0001). Adjusted for propensity scores, use of renin-angiotensin system blockers (P = .02) or statins (P = .04) was associated with better survival, and use of digoxin was associated with higher mortality (P = .007).
Conclusions:
Prognosis in patients with DMS is poor, being worse in the aged and those with renal insufficiency, atrial fibrillation, and other concomitant valvular lesions. Renin-angiotensin system blockers and statins may confer a survival benefit, and digoxin use may be associated with higher mortality in these patients.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Stenosis IV: Nursing Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis I: Introduction
Mitral Regurgitation III: Medical Management
Mitral Regurgitation IV: Nursing Management

